Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2009
A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Katsuya Hiroo, Takata Tohru, Ishikawa Takahiko, Sasaki Hidenori, Ishitsuka Kenji, Takamatsu Yasushi, Tamura Kazuo
Аннотация
Bacillus cereus is known as a serious bacterial pathogen in neutropenic patients. B. cereus is often resistant to beta-lactams, including penicillins and cephalosporins. We report a case of fatal pneumonia caused by B. cereus in a patient with newly diagnosed acute myeloid leukemia (AML) during remission induction therapy. Cefepime was started for febrile neutropenia (FN) initially and was switched to panipem/betamipron, when fulminant pneumonia supervened. The isolated strain was resistant not only to cefepime but also to panipenem/betamipron. This is the first report of fulminant infection caused by carbapenem-resistant B. cereus in a neutropenic patient. B. cereus should be kept in mind as a target of empirical treatment when neutropenic patients develop pneumonia.
Предметные рубрики MeSH
Anti-Bacterial AgentsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBacillaceae InfectionsBacillus cereusCarbapenemsFatal OutcomeHumansImmunocompromised HostLeukemia, Myeloid, AcuteLungMaleMiddle AgedNeutropeniaPneumonia, BacterialRemission InductionTomography, X-Ray Computedbeta-Lactam Resistance